tax break

The proposal draws criticism from higher-education groups.

A move by the US federal government to close tax loopholes that encourage “tax inversions” likely spooked the companies out of the multibillion dollar deal.

The two drugmakers will join forces in a $160 billion deal—if it’s given the regulatory green light.

A NJ senator and BIO are beating the drum to reinstitute a law that would channel millions into small life science companies around the country.